Development of Metal-Organic Framework-Based Dual Antibody Nanoparticles for the Highly Specific Capture and Gradual Release of Circulating Tumor Cells

Circulating tumor cells (CTCs) have been well-established as promising biomarkers that can be leveraged to gauge the prognosis of patients with cancers and to guide patient treatment efforts. Although the scarcity of CTCs within peripheral circulation and the associated phenotypic changes that they...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Mingchao, Li, Cheng, Wang, Zhili, Ding, Pi, Pei, Renjun, Wang, Qiang, Xu, Hua, Xing, Chungen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859420/
https://www.ncbi.nlm.nih.gov/pubmed/35198544
http://dx.doi.org/10.3389/fbioe.2022.806238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859420/
https://www.ncbi.nlm.nih.gov/pubmed/35198544
http://dx.doi.org/10.3389/fbioe.2022.806238

Ejemplares similares